Mergers and Acquisitions
How Is JetBlue's Stock Affected by Its Hostile Bid for Spirit?
Let's review the charts and indicators.
Are You Listening Elon? Walk Away From Twitter!
The threads of Musk's TWTR bid have been laid bare for the past two weeks.
2 Biotech Stocks to Own as M&A Potentially Gathers Steam
I like these names as stand-alone entities but they should also attract interest from larger players.
Dear Elon, Please, Oh Please, Walk Away From Twitter
A plea for the head of Tesla not to put at risk his other projects by proceeding with a deal that doesn't seem to make financial sense.
Twitter and Musk, Monday Reversal, Treasuries, Energy's Hammer, Kohl's Cash-Out?
I found two very interesting takeaways from Monday's sharp market reversal.
Elon Musk Has a Huge Problem to Overcome If He's Going to Buy Twitter
Bubbles make strange bedfellows.
Elon Musk's Bid for Twitter Is a Machiavellian Play
Let's consider how this might play out.
Charting the Twitter-Elon Musk Saga
Years ago I learned how to tell if an M&A offer was serious and had backing.
JetBlue Hits a Downdraft After Its Bid for Spirit, So Is It Time to Buy?
JetBlue's chart indicates its shares could decline even more than they already have, which could make for a good place to pick up its stock.
Berkshire Hathaway Is the Great American Conglomerate: Here's How to Trade It
Berkshire, led by the brilliant pair of Warren Buffett and Charlie Munger, has been busy of late.
The SPAC Acquiring Trump Media Isn't Worth Buying in This or Any Market
Digital World Acquisition Corp. is trading at an absurd valuation and its stock is likely to be whacked in coming months.
I Told You Buyouts Were Coming. Here's One Now -- and My Key Takeaways
Let's look at the proposed deal between First Horizon Corp. and Toronto-Dominion Bank -- and what we can learn from the planned buyout.
Buyouts Are Booming, Here's Who Might Be Next
Here are three stocks that could potentially see nice offers vs. current prices if acquired.
I'm Replacing My Acquired 2022 Stock Pick of the Year With Its Acquirer
Collegium Pharmaceutical should benefit greatly from its pending purchase of my stock pick for this year, BioDelivery Sciences International.
Crown Enters End Game in A$8.9 Billion Sale to Blackstone
Australia's largest casino operator moves into final talks with Blackstone, and the board encourages investors to approve deal.
What Recent Talk About Softbank and Alibaba Says About Both Firms
A chaotic news cycle has led to an equally wild swing in the share price of both names in the past week.
I Do Think Peloton Will Be Bought: Here's How I'm Playing It
PTON reported earnings Tuesday morning, and there's no way to sugarcoat the revised full year guidance.
Is Nike's Winning Streak About to End?
The athletic apparel maker's chart indicates its run could be over as it flashes bearish signals; meanwhile, it looks like Peloton may have put in a bottom.
Market Fun House, Bond Yields, Nord Stream 2, Raytheon, Steel, No Dice Nvidia
I had actually worried a bit that Arm was going to take Jensen Huang's eye off of the ball. That worry can now be put to bed.
Why Sony's Jump for Bungie Makes Videogame Sense
The PlayStation maker likely will introduce a subscription service later this year, hence the planned buyout of "Destiny" developer Bungie.
Charts: Kohl's Stock Gaps Higher as Activists Circle
Let's see what the charts can tell us.
Takeover Interest in Kohl's at a Fever Pitch: Here's My Plan
I always thought Kohl's was for sale, I just always thought it would be Amazon.
Activision Blizzard's Deal With Microsoft Perks Up a Portfolio of Losers
The video game maker is part of the 2022 Tax Loss Selling Recovery Portfolio and its pending acquisition has given the portfolio a lift.
Activision Blizzard: Take Profits or Buy More Amid Microsoft's Offer?
With ATVI trading around $82 we have some room to wiggle.
Microsoft to Buy Activision Blizzard: How Traders Can Play It Into Earnings
This confirms why I cast my lot with MSFT CEO Satya Nadella in the first place.
Blackstone Poised to Become Biggest Aussie Gambling Operator
After buying in at a bargain price, the private equity firm is upping its bid for troubled Crown Resorts.
More Big Deals for Health Care Eyed in 2022
As M&A investments could hit $400 billion this year, watch for buys in health technology and data, biotech, pharma and medical devices.
You're Not Wrong Being in AT&T, It's Just Not for Me
A lot is riding on successfully pulling off the Warner Media deal.
Caution Signs Are Flashing in My Mind as the New Year Begins
The biotech sector looks ripe for staging a comeback, but a significant geopolitical event could throw the entire market for a loop.
I Don't Love Biogen, But Here's How to Trade It
I'm not saying get married to the stock, I'm saying that the idea could be a trade based on two possible catalysts.